Bruno Giardina Selected Research

Bruno Giardina Research Topics

Disease

17	Neoplasms (Cancer) 02/2013 - 02/2002
8	Alzheimer Disease (Alzheimer's Disease) 11/2015 - 10/2004
6	Mitochondrial Diseases (Mitochondrial Disease) 01/2012 - 05/2003
5	Squamous Cell Carcinoma of Head and Neck 07/2007 - 02/2002
4	Muscular Dystrophies (Muscular Dystrophy) 11/2017 - 01/2003
4	Neuroblastoma 01/2016 - 11/2008
4	Carcinogenesis 01/2012 - 02/2002
4	Hypoxia (Hypoxemia) 10/2010 - 06/2006
3	Congenital Adrenal Hyperplasia (Hyperplasia, Congenital Adrenal) 01/2014 - 10/2009
3	Cardiotoxicity 01/2012 - 05/2003
3	Amyloid Plaque 03/2010 - 10/2004
3	Carcinoma (Carcinomatosis) 11/2007 - 02/2002
3	Cardiovascular Diseases (Cardiovascular Disease) 01/2007 - 11/2002
2	Rheumatoid Arthritis 04/2019 - 07/2010
2	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2015 - 01/2007
2	Hyperhomocysteinemia 01/2015 - 05/2013
2	Favism 02/2013 - 11/2008
2	Autoimmune Diseases (Autoimmune Disease) 02/2013 - 06/2009
2	Cardiomyopathies (Cardiomyopathy) 10/2012 - 11/2006
2	Neoplasm Metastasis (Metastasis) 07/2012 - 10/2010
2	Hemolysis 07/2011 - 11/2008
2	Hemolytic Anemia 05/2011 - 11/2008
2	Hypotension (Low Blood Pressure) 01/2010 - 07/2005
2	Acidosis 06/2009 - 01/2007
2	Glucosephosphate Dehydrogenase Deficiency 01/2009 - 08/2008
2	Renal Insufficiency (Renal Failure) 10/2008 - 01/2007
2	Hyperlipidemias (Hyperlipidemia) 07/2007 - 08/2004
2	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 02/2002 - 01/2002
1	Malaria 01/2022
1	Burns 11/2015
1	Pathologic Processes 01/2015
1	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 01/2015
1	Brain Concussion (Cerebral Concussion) 04/2014
1	Traumatic Brain Injuries (Traumatic Brain Injury) 04/2014

Drug/Important Bio-Agent (IBA)

11	Proteins (Proteins, Gene)FDA Link 01/2016 - 10/2006
8	Amyloid beta-PeptidesIBA 01/2016 - 10/2004
7	Pharmaceutical PreparationsIBA 11/2015 - 01/2007
6	Peptides (Polypeptides)IBA 11/2015 - 10/2004
6	AntioxidantsIBA 04/2014 - 02/2002
6	HomocysteineIBA 05/2013 - 02/2002
6	EnzymesIBA 01/2012 - 06/2004
5	Dystroglycans (Dystroglycan)IBA 01/2015 - 01/2003
5	Oxidoreductases (Dehydrogenase)IBA 05/2013 - 11/2006
5	Methionine (L-Methionine)FDA Link 03/2010 - 02/2002
4	Amyloid (Amyloid Fibrils)IBA 01/2016 - 12/2008
4	Folic Acid (Vitamin M)FDA LinkGeneric 05/2013 - 02/2002
4	AnthracyclinesIBA 10/2012 - 09/2003
4	Doxorubicin (Adriamycin)FDA LinkGeneric 10/2012 - 05/2003
4	Free RadicalsIBA 03/2010 - 05/2003
4	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 01/2008 - 07/2004
4	LigandsIBA 01/2008 - 07/2004
3	Glycoproteins (Glycoprotein)IBA 11/2017 - 01/2003
3	Amino Acids FDA Link 01/2015 - 11/2005
3	NitratesIBA 04/2014 - 07/2005
3	Glutathione (Reduced Glutathione)IBA 04/2014 - 07/2007
3	DNA (Deoxyribonucleic Acid)IBA 01/2013 - 11/2010
3	Antineoplastic Agents (Antineoplastics)IBA 10/2012 - 11/2006
3	Daunorubicin (Cerubidine)FDA LinkGeneric 10/2012 - 09/2003
3	Tumor Biomarkers (Tumor Markers)IBA 10/2010 - 11/2007
3	Glucose (Dextrose)FDA LinkGeneric 02/2010 - 01/2009
3	Adenosine Triphosphate (ATP)IBA 06/2009 - 10/2008
3	PPAR alphaIBA 01/2008 - 08/2004
3	PPAR gammaIBA 01/2008 - 08/2004
3	Uric Acid (Urate)IBA 07/2007 - 02/2002
2	AntigensIBA 04/2019 - 06/2004
2	Collagen Type II (Type II Collagen)IBA 04/2019 - 07/2010
2	DystrophinIBA 11/2017 - 01/2003
2	ResveratrolIBA 01/2015 - 09/2010
2	Matrix Metalloproteinases (MMPs)IBA 01/2015 - 11/2007
2	Reactive Oxygen Species (Oxygen Radicals)IBA 04/2014 - 03/2010
2	Steroid 21-Hydroxylase (21 Hydroxylase)IBA 01/2014 - 10/2009
2	UGT1A1 enzymeIBA 01/2013 - 02/2010
2	daunorubicinolIBA 10/2012 - 11/2006
2	adriamycinolIBA 10/2012 - 11/2006
2	Biomarkers (Surrogate Marker)IBA 07/2012 - 01/2012
2	Caspase 3 (Caspase-3)IBA 03/2009 - 12/2008
2	glutathione S-transferase M1IBA 09/2007 - 02/2007
2	ThiazolidinedionesIBA 07/2007 - 08/2004
2	Insulin (Novolin)FDA Link 07/2007 - 08/2004
2	Fibric Acids (Fibrates)IBA 07/2007 - 08/2004
2	Oxygen (Dioxygen)IBA 06/2006 - 09/2005
2	Taurine FDA Link 03/2003 - 01/2003
1	Carbon MonoxideIBA 01/2022
1	Heme (Haem)IBA 01/2022
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2022
1	HLA-DRB1*04 antigenIBA 04/2019
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 04/2019
1	Nerve Growth Factors (Neurotrophins)IBA 01/2016
1	GlobinsIBA 01/2016
1	Sulfhydryl Compounds (Thiols)IBA 01/2015
1	Vitamin B Complex (B Vitamins)IBA 01/2015
1	StilbenesIBA 01/2015
1	Superoxide DismutaseIBA 01/2015
1	GelatinasesIBA 01/2015
1	PolyphenolsIBA 01/2015
1	S-Adenosylmethionine (Ademetionine)IBA 01/2015
1	NitritesIBA 04/2014
1	NeuroglobinIBA 04/2014

Therapy/Procedure

9	Therapeutics 07/2011 - 02/2002
2	Drug Therapy (Chemotherapy) 10/2010 - 08/2004